Angioplasty with the scepter C dual lumen balloon catheter and postprocedural result evaluation in patients with subarachnoid hemorrhage related vasospasms

Table 3 Comparison to other series regarding the endovascular treatment, the angiographic and the clinical improvement, and the favourable outcome. Comparison to other series concerning primary and secondary endpoints

Series	No. Of patients	Endovascular Treatment	Angiographic improvement	Clinical improvement	Favourable outcome (mRS 0–2)
Bejjani et al., 1998 [15]	31	TBA +/− papavarine	N/A	72%	80%
Coyne et al., 1994 [14]	13	TBA	N/A	31	38
Eskridge et al., 1994 [13]	50	TBA	N/A	61	N/A
Fujii et al., 1995 [16]	19	TBA	94	63	89
Polin et al., 2000	38	TBA +/− papaverine	82	29	53
Jestaedt et al., 2008 [25]	38	TBA	100	N/A	21
Hoh and Ogilvy 2005 [26]	530	TBA	N/A	62	N/A
Jun et al., 2010	60	TBA +/−verapamil	100	N/A	61 (the only IA group incl.)
Biondi et al., 2004	25	Nimodipine	42	76	72
Feng et al., 2002	29	Verapamil	34	29	N/A
Badjatia et al., 2004	18	Nicardipine	100	42	N/A
Our study	17	TBA +/− papaverine or nimodipine	100	23	53

ISSN: 1471-2377